UnknownNot Applicable

Safety and Efficacy of GPOEM in the Treatment of Gastroparesis

Italy40 participantsStarted 2020-06-01

Plain-language summary

The purpose of this study is to assess the clinical efficacy and safety in the treatment of gastroparesis.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Gastroparesis (GCSI \> 2 OR Gastric emptying half-time \> 180 min OR gastric retention at 120 min \> 60% OR good response to botulinum if former criteria not met) Exclusion Criteria: * Age \< 18 years * Inability to understand protocol

What they're measuring

Clinical efficacy

Timeframe: 1, 3, 6, 12, 24 months

Functional efficacy

Timeframe: 3, 12, 24 months

Complications

Timeframe: peri-operative time (48 hours)

Trial details

NCT IDNCT04349670

SponsorIRCCS San Raffaele

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-04-01

View on ClinicalTrials.gov More Gastroparesis trials